Harrow (HROW) EPS (Basic) Growth (3y) (2013 - 2026)
Harrow (HROW) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 53.26% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.07% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.72% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -47.34% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 65.02% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -19.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -78.78% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 262.79% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -100.00% |
| 10 | Harrow | 1.23 Bn | 1.14 Bn | 27.05 Mn | -49.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.83% |
| Dec 31, 2025 | 65.10% |
| Sep 30, 2025 | 28.56% |
| Jun 30, 2025 | 37.66% |
| Mar 31, 2025 | -77.11% |
| Dec 31, 2024 | 39.31% |
| Sep 30, 2024 | 27.12% |
| Jun 30, 2024 | -17.84% |
| Mar 31, 2024 | -242.00% |
| Dec 31, 2023 | -106.06% |
| Sep 30, 2023 | -33.77% |
| Jun 30, 2023 | -141.01% |
| Mar 31, 2023 | 23.94% |
| Dec 31, 2022 | -28.62% |
| Sep 30, 2022 | 18.90% |
| Jun 30, 2022 | -36.72% |
| Mar 31, 2022 | -29.97% |
| Dec 31, 2021 | -32.48% |
| Sep 30, 2021 | -37.21% |
| Jun 30, 2021 | -42.88% |